Express Scripts (ESRX) Tops Q1 EPS by 1c

Express Scripts (NASDAQ: ESRX) reported Q1 EPS of $1.77, $0.01 better than the analyst estimate of $1.76. Revenue for the quarter came in at $24.77 million versus the consensus estimate of $24.86 million.

GUIDANCE:

Express Scripts sees Q2 2018 EPS of $2.18-$2.22, versus the consensus of $2.29.

• 2018 Guidance
• All previously provided guidance remains the same except for consolidated adjusted earnings per diluted share and diluted weighted average shares outstanding guidance due to the suspension of the Company's share repurchase program.

For earnings history and earnings-related data on Express Scripts (ESRX) click here.

You May Also Be Interested In

• Medtronic (MDT) Tops Q1 EPS by 6c, Beats on Revenue; Offers FY27 EPS Guidance
• RBC Capital Resumes BorgWarner (BWA) at Outperform
• PG&E downgraded by Wells Fargo, BMO as California wildfire reform falls short